Adial Pharmaceuticals, Inc. (AZR) bonds
AZRNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ADIL
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q/A on Oct 21, 2026Score 5/30
Share price
Not available yet
Price, market cap and P/E appear here once daily prices are connected.
Debt
Borrowings on the balance sheet, Jun 30, 2026
Adial Pharmaceuticals reports no long-term debt line
Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.
Notes and loans outstanding
As tagged in Adial Pharmaceuticals's 10-K for the period ended Nov 20, 2017
| Issue | Coupon | Amount issued |
|---|---|---|
| Convertible Notes Convertible | 15.00% | – |
| Subordinated Debt | 100.00% | $115.00K |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-K.